Grace Therapeutics, Inc.
Develops improved drugs for rare neurological diseases using novel drug delivery technologies.
GRCE | NDAQ
Overview
Corporate Details
- ISIN(s):
- US00439U1043 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 103 CARNEGIE CENTER, 8540 PRINCETON
- Website:
- https://www.gracetx.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Grace Therapeutics, Inc. is a late-stage biopharmaceutical company focused on developing and commercializing drug candidates for rare and orphan diseases, with a particular emphasis on neurological conditions. The company utilizes novel drug delivery technologies to improve the performance of currently marketed drugs. Its lead clinical asset, GTx-104, is an intravenous (IV) formulation of nimodipine for the treatment of aneurysmal subarachnoid hemorrhage (aSAH), an acute brain injury. Currently in a pivotal Phase 3 trial, GTx-104 is designed to overcome the significant limitations of the existing oral standard of care. The asset has been granted Orphan Drug Designation by the U.S. FDA, and the company is supported by a strong, multi-layered intellectual property portfolio.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Grace Therapeutics, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Grace Therapeutics, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Grace Therapeutics, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
